Alnylam Pharmaceuticals (ALNY) Tax Rate (2009 - 2026)
Alnylam Pharmaceuticals' (ALNY) quarterly Tax Rate came in at 7.49% in Q2 2026, up 8233.0% YoY from 0.09% in Q2 2025, and up 5.96% on a QoQ basis from 7.07% in Q1 2026.
Alnylam Pharmaceuticals (ALNY) Tax Rate (2009 - 2026) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 14 years of Tax Rate data on file, last reported at 7.49% in Q2 2026.
- Quarterly Tax Rate rose 8233.0% year-over-year to 7.49% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1.1% (down 1857.0% YoY) and the FY2025 annual result came in at 2.91%, down 2338.0% from the prior year.
- Tax Rate climbed to 7.49% in Q2 2026, from 7.07% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 56.81% in Q4 2024 to a low of 670.73% in Q1 2025.
- A 5-year average of 42.61% and a median of 0.83% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2025 — Tax Rate tumbled 66704 bps — and 2026, when it surged 67780 bps.
- Tracing ALNY's Tax Rate over 5 years: stood at 0.23% in 2022, then surged by 42 bps to 0.13% in 2023, then soared by 42846 bps to 56.81% in 2024, then tumbled by 152 bps to 29.31% in 2025, then soared by 126 bps to 7.49% in 2026.
- The last three Tax Rate figures came in at 7.49% (Q2 2026), 7.07% (Q1 2026), and 29.31% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 1.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.49% |
| Jun 30, 2026 | 7.49% |
| Jun 30, 2026 | 7.49% |
| Mar 31, 2026 | 7.07% |
| Mar 31, 2026 | 7.07% |
| Mar 31, 2026 | 7.07% |
| Dec 31, 2025 | -29.31% |
| Dec 31, 2025 | -29.31% |
| Dec 31, 2025 | -29.31% |
| Sep 30, 2025 | -4.32% |
| Sep 30, 2025 | -4.32% |
| Sep 30, 2025 | -4.32% |
| Jun 30, 2025 | -87.45% |
| Jun 30, 2025 | -87.45% |
| Jun 30, 2025 | -87.45% |
| Mar 31, 2025 | -670.73% |
| Mar 31, 2025 | -670.73% |
| Mar 31, 2025 | -670.73% |
| Dec 31, 2024 | 56.81% |
| Dec 31, 2024 | 56.81% |